PERSISTENT CORNEAL epithelial
|
|
- Candice Lewis
- 6 years ago
- Views:
Transcription
1 CLINICAL SCIENCES Amniotic Membrane Inlay and Overlay Grafting for Corneal Epithelial Defects and Stromal Ulcers Erik Letko, MD; Stephen U. Stechschulte, MD; Kenneth R. Kenyon, MD; Nadia Sadeq, MD; Tatiana R. Romero, MD; C. Michael Samson, MD; Quan D. Nguyen, MD; Stephanie L. Harper, MD; Jonathan D. Primack, MD; Dimitri T. Azar, MD; Martin Gruterich, MD; Claes H. Dohlman, MD; Stefanos Baltatzis, MD; C. Stephen Foster, MD Objectives: To determine the effect of amniotic membrane transplantation (AMT) on persistent corneal epithelial defects (PEDs) and to compare the efficacy between inlay and overlay techniques. Methods: Thirty patients (30 eyes) underwent AMT for PED. The use of AMT was restricted to patients in whom all previous measures, including bandage contact lens and tarsorrhaphy, had failed. The amniotic membrane was placed on the surface of the cornea in overlay (group A) or inlay (group B) fashion. Results: The PED healed after the first AMT in 21 eyes (70%) within an average of 25.5 days after surgery and recurred in 6 eyes (29%). Among the 22 eyes treated with an overlay AMT (group A), the PED healed after the first AMT in 14 eyes (64%) within an average of 24.5 days and recurred in 4 eyes (29%). Among the 8 eyes treated with an inlay AMT (group B), the PED healed within an average of 27.4 days after AMT, which did not statistically significantly differ from group A (P=.72). The PED healed after the first AMT in 7 eyes (88%) and recurred in 2 (29%) of 7 eyes. Conclusions: The AMT can be helpful in the treatment of PED in which all other conventional management has failed. However, the success rate in our study was not as high as that previously reported, and our results showed a high incidence of recurrences of epithelial defects. We did not find any difference between overlay and inlay techniques in terms of healing time and recurrence rate. Arch Ophthalmol. 2001;119: From the Immunology and Uveitis Service (Drs Letko, Romero, Samson, Nguyen, Harper, and Foster) and Cornea Service (Drs Stechschulte, Primack, Azar, and Dohlman), Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston; Cornea Consultants, Boston (Drs Stechschulte and Kenyon); Ludwigs Maximilian Universitat Augenklinik, München, Germany (Drs Kenyon and Gruterich); Al-Bahar Ophthalmology Center, IBN Sina Hospital, Safat, Kuwait (Dr Sadeq); and General Hospital of Athens, University Eye Clinic, Athens Medical School, Athens, Greece (Dr Baltatzis). PERSISTENT CORNEAL epithelial defects (PEDs) induced by primary ocular surface disorders, such as chemical injury, neurotrophic keratitis, and keratoconjunctivitis sicca, or associated with systemic diseases, such as ocular cicatricial pemphigoid, Stevens- Johnson syndrome, or toxic epidermal necrolysis, are extremely difficult to treat. Such disorders cause prolonged inflammation of the ocular surface, damaging corneal stem cells and epithelial basement membrane (BM) 1 and resulting in corneal scarring, 2 neovascularization, 3 and decreased vision. In addition, matrix metalloproteinases produced by keratocytes, 4 epithelial cells, and neutrophils 5 can cause progressive stromal ulceration with risk of corneal perforation. Previous studies have shown that the epithelial BM facilitates migration of epithelial cells, 6 reinforces adhesion of basal epithelial cells, 7,8 promotes epithelial differentiation, 9-12 and militates against epithelial apoptosis. 13,14 Even when an extensive PED develops, in the presence of an intact BM, the corneal surface can be replaced by conjunctivally derived epithelium that can acquire a corneal-type phenotype, ie, express 55-kd keratin. 15 Human placental amnion is composed of a single epithelial cell layer, a BM, and an avascular stroma. 16 Both collagens IV and VII, components of corneal epithelial BM, are present in the BM of amniotic membrane. 17 Inaddition,collagensIthrough III and V are also present in human placental amnion. 18 Amniotic epithelium produces basic fibroblast growth factor, hepatocyte growth factor, and transforming growth factor. 19 Amnion prevents inflammatory cell infiltration 20 and reduces apoptosis in keratocytes after transplantation onto the corneal surface. 21 It is noteworthy that matrix metalloproteinases have also been identified in human amniotic membrane. 22 Davis 23 first reported on the use of amniotic membrane for skin transplantation in Since then, living rather than preserved amniotic membrane has been used for various purposes, 24 and in 1940, De Roth 25 first reported its use in the eye, using fresh amnion for the reconstruction of conjunctival defects. In the early 1990s, Batlle and Perdomo 26 reintroduced the use 659
2 PATIENTS AND METHODS Thirty patients (30 eyes) who underwent AMT for PED with or without stromal ulceration between 1997 and 1999 were studied (Table 1). The duration of corneal epithelial defects varied from 1 to 6 weeks. We used a progressively staged approach in the management of PED. Thus, all patients were initially treated with removal of toxic topical antibiotics, lubrication, punctum occlusion if appropriate, and then with a bandage contact lens. If these techniques were unsuccessful, tarsorrhaphy was performed. Amniotic membrane transplantation was reserved for patients in whom all other measures were unsuccessful. In patients who refused to have tarsorrhaphy, mostly for cosmetic reasons, AMT was performed after treatment with bandage contact lenses failed. Human amniotic membrane grafts were prepared and preserved as previously described. 31 An informed consent was obtained from each patient before the surgery. After peribulbar or topical anesthesia, the base of the epithelial defect or stromal ulcer was debrided with a microsponge, and the poorly adherent epithelium surrounding the defect or ulcer was removed. The amniotic membrane was placed on the surface of the cornea in overlay (group A) or inlay (group B) fashion (Figure). After each AMT, a bandage contact lens was applied and 0.35% ciprofloxacin hydrochloride eyedrops 4 times a day and 1% rimexolone eyedrops 4 times a day were administered in the postoperative period. The amniotic membrane dissolved under the bandage contact lens during a period of 4 weeks after surgery. The bandage contact lens was removed when the epithelial defect had healed. GROUP A: OVERLAY AMT Patients with large epithelial defects with or without stromal ulcer with clinically deficient limbal stem cell function were treated with overlay AMT. Overlay grafts approximately 12 to 14 mm in diameter covered the entire corneal, limbal, and perilimbal surfaces. The overlay AMT was placed with the epithelial BM side up and secured by interrupted 10-0 polyglactin sutures to the surrounding conjunctiva. In some cases, a running 10-0 polyglactin suture was placed in the midperipheral cornea. GROUP B: INLAY AMT Patients with localized PED ( 20% of corneal surface) with or without stromal ulceration received inlay AMT. Inlay grafts were cut to fit the size of the epithelial defect or stromal ulceration as described by Lee and Tseng. 31 These grafts were placed with the epithelial BM side up and secured to the edge of the defect by interrupted 10-0 polyglactin sutures. After each AMT, a bandage contact lens was applied and 0.35% ciprofloxacin hydrochloride eyedrops 4 times a day and 1% rimexolone eyedrops 4 times a day were administered in the postoperative period. The amniotic membrane dissolved under the bandage contact lens during a period of 4 weeks after surgery. The bandage contact lens was removed when the epithelial defect had healed. of amniotic membrane transplantation (AMT) for ocular disorders in North America. Kim and Tseng 27 then showed in 1995 that preserved amniotic membrane facilitated corneal surface reconstruction in rabbits after epithelial removal and limbal lamellar keratectomy. Amniotic membrane transplantation has recently been used for ocular surface reconstruction in patients after chemical burn, 28 in patients with advanced ocular cicatricial pemphigoid and Stevens-Johnson syndrome, 29 and for pterygium excision, 30 conjunctival surface reconstruction, 12 sterile corneal ulceration, 31 and symptomatic bullous keratopathy. 32 The purpose of this study was to determine the effect of human amniotic membrane grafts on PEDs of the cornea with or without stromal ulcers and to compare the efficacy between inlay and overlay techniques. RESULTS OVERALL OUTCOMES The overall results for all 30 cases are summarized in Table 2. The mean age of patients was 55.3 years (range, 9-78 years). The male-female ratio was 2:1. The mean follow-up time after AMT was 8.2 months (range, 1-32 months). The mean visual acuity before and after the surgery was 0.04 (range, ) and 0.05 (range, ), respectively (P=.45). The PEDs healed within an average of 25.5 days (range, 5-68 days) after surgery. The epithelial defect healed after the first AMT in 21 eyes (70%). In 9 eyes (30%), the defect persisted after the first AMT. The epithelial defect recurred after the first AMT in 6 (29%) of 21 eyes. The average time to recurrence of the defect was 5.2 weeks (range, 2-9 weeks). Thus, the PED did not heal or recurred after the first AMT in 15 (50%) of 30 eyes. During follow-up, AMT was repeated in 5 patients, and in 1 case the recurrence was successfully treated with a bandage contact lens. The first AMT was accompanied by additional surgical procedures in 18 eyes. These included tarsorrhaphy (16 eyes), superficial keratectomy (2 eyes), and lamellar keratoplasty (1 eye). Among the 16 patients in whom AMT was performed along with tarsorrhaphy, 12 defects (75%) healed; of these, 4 (33%) recurred after the first AMT. Interestingly, we observed similar results in patients who were treated with AMT alone. In 9 (64%) of 14 patients the defect healed, and in 2 (22%) of the 9 it recurred. GROUP A Among the 22 eyes treated with an overlay AMT, the mean age of patients was 53.1 years (range, years). The male-female ratio was 7:4. The mean follow-up time was 6.8 months (range, 1-22 months) after AMT. The mean visual acuity before and after the surgery was 0.05 (range, ) and 0.06 (range, ), respectively (P=.54). The corneal epithelial defect healed within an average of 24.5 days (range, 5-68 days) after surgery. The epithelial defect healed after the first AMT in 14 eyes (64%). The epithelial defect recurred after the first AMT in 4 (29%) of 14 eyes. The average time to the recurrence of the defect was 660
3 Table 1. Data on the 2 Patient Groups* Visual Acuity Epithelium Patient/ Sex/Age, y Cause of PED Immunosuppressive Therapy Previous Treatment Before No. of Associated AMT Final AMTs Procedure State HT, d Recurrence, wk Follow-up, mo Patients Treated With oamt 1/M/67 PI None BCL 20/400 20/400 1 None H /M/37 KCS None SCL 20/150 20/100 1 None H 5 No 5 3/F/58 SS Methotrexate BCL CF HM 1 None H None NH NA NA 4/F/58 PI None TAR CF LP 1 SK H 14 No 1 TAR 5/F/55 TEN Cyclosporine, LK 20/400 HM 1 TAR H azathioprine 6/M/71 RK None BCL, TAR HM HM 1 TAR NH NA NA 2 7/M/41 EK None BCL CF CF 1 None NH NA NA 7 8/F/75 OCP IV immunoglobulin BCL 20/400 20/200 1 None H 20 No 12 9/F/70 OCP None SCL 20/200 20/200 1 None NH NA NA 7 2 TAR NH NA NA 10/M/54 AKC None TAR, LK HM HM 1 TAR, LK H 29 No 7 11/F/75 PBK None PK, TAR, BCL HM CF 1 TAR H TAR H 47 No 12/M/43 ChemB None TAR, BCL CF 20/60 1 TAR H 50 No 8 13/M/35 SJS Cyclosporine PK, TAR 20/400 20/80 1 TAR H 68 No 10 14/F/34 GVHD Cyclosporine TAR, SCL CF CF 1 TAR H 35 No 15 15/M/27 PI None PK, TAR HM HM 1 None H 44 No 19 16/M/40 PI None BCL HM HM 1 None H 8 No 2 17/M/63 KCS None BCL 20/400 20/400 1 None NH NA NA 3 18/M/70 PI None BCL CF CF 1 None NH NA NA 5 19/M/55 RES None BCL 20/400 20/200 1 None H 11 No 1 20/M/44 ChemB None BCL, TAR 20/60 20/300 1 None NH NA NA 2 21/M/34 ChemB None BCL, TAR CF CF 1 TAR NH 5 2 TAR H /F/63 PAN None BCL, SK, TAR 20/200 CF 1 TAR NH NA NA 5 Patients Treated With iamt 1/F/74 PI None TAR, SCL LP LP 1 TAR H 30 No 14 2/M/74 RK None TAR, SCL HM CF 1 TAR H 30 No 3 3/M/56 PI, HSK None PK, SK 20/400 20/400 1 SK H 20 No 7 4/M/59 ChemB None LK, SK, MMG HM HM 1 TAR H /F/73 OCP Dapsone TAR, BCL HM 20/200 1 TAR H TAR H 28 No 6/M/9 Aniridia None PK, TAR CF CF 1 TAR NH NA NA 12 7/M/78 AKC Dapsone, PK, CL, TAR HM HM 1 TAR H 40 No 32 cyclosporine 8/M/66 PI None BCL, TAR LP HM 1 TAR H 24 No 5 *PED indicates persistent epithelial defect; AMT, amniotic membrane transplantation; oamt, overlay AMT; iamt, inlay AMT; HT, healing time; PI, postinfectious; KCS, keratoconjunctivitis sicca; SS, Sjögren syndrome; TEN, toxic epidermal necrolysis; RK, radiation keratopathy; EK, exposure keratitis; OCP, ocular cicatricial pemphigoid; AKC, atopic keratoconjunctivitis; PBK, pseudophakic bullous keratopathy; ChemB, chemical burn; SJS, Stevens-Johnson syndrome; GVHD, graft-vs-host disease; RES, recurrent erosion syndrome; PAN, polyarteritis nodosa; HSK, herpes simplex keratitis; IV, intravenous; BCL, bandage contact lens; SCL, scleral contact lens; TAR, tarsorrhaphy; LK, lamellar keratoplasty; PK, perforating keratopathy; SK, superficial keratectomy; CF, counting fingers; HM, hand motions; LP, light perception; H, healed; NH, not healed; and NA, not applicable. 4.5 weeks (range, 2-9 weeks). The PED did not heal or recurred after the first AMT in 4 patients (45%). GROUP B Among the 8 eyes treated with an inlay AMT, the mean age of patients was 61.1 years (range, 9-78 years). The malefemale ratio was 3:1. The mean follow-up time was 12.2 months (range, 2-32 months) after AMT. The mean visual acuity before and after the surgery was 0.02 (range, ) and 0.03 (range, ), respectively (P=.35). The corneal epithelial defect healed within an average of 27.4 days (range, 7-41 days) after AMT, which did not statistically significantly differ from group A (P=.72). The epithelial defect healed after the first AMT in 7 eyes (88%). The epithelial defect persisted after the first AMT in 1 eye (12%). The epithelial defect recurred after the first AMT in 2 (29%) of 7 eyes. The PED did not heal or recurred after the first AMT in 3 (38%) of 8 eyes. There was not a statistically significant difference (P=.53) in the average time to the recurrence of epithelial defect between group B (6.5 weeks) and group A. COMMENT The epithelial defects healed after the first AMT in 70% (21/ 30) of all eyes in our study. By comparison, Lee and Tseng 31 reported an initial success rate of 90% (10/11). In addi- 661
4 A B Running Intrastromal Suture 10-0 Polyglactin Amniotic Membrane 9-0 Polyglactin Overlay Graft Amniotic Membrane Graft Amniotic Membrane Graft Amniotic membrane grafting, inlay (A) and overlay (B) techniques. Note that the running suture in the overlay technique is optional, at the surgeon s discretion. Table 2. Results in Groups A and B and the 2 Groups Combined* Group A (n = 22) Group B (n=8) Combined (n = 30) Mean age, y Mean visual acuity Before AMT Final Healed PEDs after 14 (64) 7 (88) 21 (70) first AMT, No. (%) Mean healing time, d Recurrence after 4/14 (29) 2/7 (29) 6/21 (29) first AMT, No. (%) Mean interval to recurrence, wk Not healed and recurrent 10 (45) 3 (38) 13 (43) epithelial defects, No. (%) Mean follow-up, mo *Group A underwent overlay amniotic membrane transplantation (AMT); group B, inlay AMT. PEDs indicates persistent epithelial defects. tion, we found a higher recurrence rate (29%) after the first AMT than that previously reported. 31 Given the intrinsic diversity among PED cases, it might be hypothesized that differences in surgical techniques and/or causes of the epithelial defects might explain these outcome differences. Lee and Tseng 31 did not observe any recurrence of epithelial defect when the amniotic membrane graft was placed into the stromal ulcer and secured by interrupted sutures to the edge of the defect. The corneal epithelium grew over the amniotic membrane graft. We used an identical technique in group B, yet the incidence of recurrences was 29%. Again, the difference in cause of the epithelial defects and extent of damage to the ocular surface might explain this higher rate of recurrences. Interestingly, our results show that there was no difference in recurrence rate between overlay and inlay techniques, although there was a slight difference in success rate after the first AMT when the inlay technique was used. In addition to using amnion in the inlay fashion, we used the amniotic membrane graft to cover the entire corneal surface and perilimbal conjunctiva in some cases, similar to a bandage contact lens. This technique has been used successfully by others in the treatment of patients with symptomatic bullous keratopathy, 32 limbal stem cell deficiency of various causes, 33 and stromal defects after photorefractive keratectomy. 20 Among our patients, autoimmune diseases affecting the ocular surface were involved in the pathogenesis of epithelial defects and stromal ulcers in 3 of 6 patients with recurrence of epithelial defect. One patient had ocular cicatricial pemphigoid, 1 had toxic epidermal necrolysis, and the other had Sjögren syndrome. Tsubota et al 29 treated a group of patients with ocular cicatricial pemphigoid or Stevens-Johnson syndrome with AMT and limbal stem cell transplantation. They demonstrated that the entire ocular surface with or without PED in this group of patients can be restored by AMT along with limbal allograft and tarsorrhaphy, followed by systemic immunosuppression and topical administration of artificial tears derived from autologous serum. The authors reported a stable ocular surface during the follow-up in 9 of 11 patients. However, final visual acuity remained less than 0.1 in all but 3 patients. The growth of new epithelium, particularly in patients with multiple causative factors involved in the pathogenesis of epithelial or stromal defects, may be altered by the absence of direct contact with BM. Tseng et al 33 recently showed that AMT alone is superior to AMT with limbal allotransplantation in patients with partial limbal stem cell deficiency, whereas limbal allotransplantation with AMT is needed for patients with total limbal stem cell deficiency. 662
5 Active conjunctival inflammation can complicate the postoperative period after ocular surface reconstruction, 34 with resultant failure of the ocular surface. Keratoprosthesis may then be the procedure of last resort in such cases. 35 Shimazaki et al 19 claimed that the epithelium of the amniotic membrane may survive up to 70 days after cryopreservation. Their study showed that living epithelium of amnion produces basic fibroblast growth factor, hepatocyte growth factor, and transforming growth factor. 19 Whether cryopreserved transplanted amniotic membrane confers such benefit is uncertain. Because the epithelium of amnion expresses neither HLA class I nor II antigens, the use of systemic immunosuppressive therapy in AMT is not required. Amniotic membrane transplantation can improve visual acuity by both corneal surface restoration and improvement of corneal transparency. 31 In our study, the average visual acuity improved after AMT, but the difference between the preoperative and final visual acuities was not statistically significant (P=.45). A statistically significant difference between visual acuity before AMT and final visual acuity was not observed in either group A (P=.54) or group B (P=.35). These results suggest that the effect of AMT on vision rehabilitation is very limited and is unrelated to the technique used. In summary, our study confirms the results of previous reports that AMT can be helpful in the treatment of epithelial defects and stromal ulcers in which all other conventional management has failed. However, the success rate in our study was not as high as that previously reported, and our results showed a high incidence of recurrences of epithelial defects. We therefore believe that AMT for PED, with or without stromal ulceration, should not be used as first- or even second-line therapy. The use of AMT for PED should be reserved for cases in which removal of medications toxic to the epithelium, aggressive lubrication and ocular surface protection (eg, bandage contact lens and tarsorrhaphy), and control of inflammation have failed to promote closure of the defect. We did not find any difference between overlay and inlay techniques in terms of healing time, recurrence rate, and effect on vision rehabilitation. Further studies are required to confirm our results, to compare AMT with other strategies in treatment of PEDs and stromal ulcers, to compare the results after different techniques of transplantation, and to estimate the outcomes in various groups of patients. Accepted for publication December 15, Corresponding author and reprints: C. Stephen Foster, MD, Immunology Service, Massachusetts Eye and Ear Infirmary, 243 Charles St, Boston, MA ( fosters@uveitis.org). REFERENCES 1. Tsai RJF, Tseng SCG. Effect of stromal inflammation on the outcome of limbal transplantation for corneal surface reconstruction. Cornea. 1995;14: Foster CS, Zelt RP, Mai-Phan T, Kenyon KR. Immunosuppression and selective inflammatory cell depletion. Arch Ophthalmol. 1982;100: Thoft RA, Friend J, Murphy HS, et al. Ocular surface epithelium and corneal vascularization in rabbits, I. Invest Ophthalmol Vis Sci. 1979;18: Brown SI, Hook CW. Isolation of stromal collagenase in corneal inflammation. Am J Ophthalmol. 1971;72: Kenyon KR, Berman M, Rose J, Gage J. Prevention of stromal ulceration in the alkali-burned rabbit cornea by glued-on contact lens. Invest Ophthalmol Vis Sci. 1979;18: Terranova VP, Lyall RM. Chemotaxis of human gingival epithelial cells to laminin: a mechanism for epithelial cell apical migration. J Periodontol. 1986;57: Khodadoust AA, Silverstein AM, Kenyon KR, Dowling JE. Adhesion of regenerating corneal epithelium. Am J Ophthalmol. 1968;65: Sonnenberg A, Calafat J, Janssen H, et al. Integrin 6/ 4 complex is located in hemidesmosomes, suggesting a major role in epidermal cell basement membrane adhesion. J Cell Biol. 1991;113: Barcellos-Hoff MH, Aggeler J, Ram TG, Bissell MJ. Functional differentiation and alveolar morphogenesis of primary mammary cultures on reconstituted basement membrane. Development. 1989;105: Guo M, Grinnel F. Basement membrane and human epidermal differentiation in vitro. J Invest Dermatol. 1989;93: Streuli CH, Bailey N, Bissell MJ. Control of mammary epithelial differentiation. J Cell Biol. 1991;115: Tseng SCG, Prabhasawat P, Lee SH. Amniotic membrane transplantation for conjunctival surface reconstruction. Am J Ophthalmol. 1997;124: Boudreau N, Sympson CJ, Werb Z, Bissell MJ. Suppression of ICE and apoptosis in mammary epithelial cells by extracellular matrix. Science. 1995;267: Boudreau N, Werb Z, Bissell MJ. Suppression of apoptosis by basement membrane requires three-dimensional tissue organization and withdrawal from the cell cycle. Proc Natl Acad SciUSA. 1996;93: Kurpakus MA, Stock El, Jones JCR. The role of the basement membrane in differential expression of keratin proteins in epithelial cells. Dev Biol. 1992;150: van Herendael BJ, Oberti C, Brosens I. Microanatomy of the human amniotic membranes. Am J Obstet Gynecol. 1978;131: Fukuda K, Chikama T, Nakamura M, Nishida T. Differential distribution of subchains of the basement membrane components type IV collagen and laminin among the amniotic membrane, cornea, and conjunctiva. Cornea. 1999;18: Polzin WJ, Lockrow EG, Morishige WK. A pilot study identifying type V collagenolytic activity in human amniotic fluid. Am J Perinatol. 1997;14: Shimazaki J, Shinozaki N, Tsubota K. Transplantation of amniotic membrane and limbal autograft for patients with recurrent pterygium associated with symblepharon. Br J Ophthalmol. 1998;82: Choi YS, Kim JY, Wee WR, Lee JH. Effect of the application of human amniotic membrane on rabbit corneal wound healing after excimer laser photorefractive keratectomy. Cornea. 1998;17: Wang M, Gray T, Prabhasawat P, et al. Corneal haze is reduced by amniotic membrane matrix in excimer laser photoablation in rabbits [abstract]. Invest Ophthalmol Vis Sci. 1997;38(suppl): Athayde N, Edwin SS, Romero R. A role for matrix metalloproteinase-9 in spontaneous rupture of the fetal membranes. Am J Obstet Gynecol. 1998;179: Davis JW. Skin transplantation with a review of 550 cases at The Johns Hopkins Hospital. Johns Hopkins Med J. 1910;15: Trelford JD, Trelford-Sauder M. The amnion in surgery, past and present. Am J Obstet Gynecol. 1979;134: De Roth A. Plastic repair of conjunctival defects with fetal membrane. Arch Ophthalmol. 1940;23: Batlle JF, Perdomo FJ. Placental membranes as a conjunctival substitute [abstract]. Ophthalmology. 1993;100:107. Abstract 9A. 27. Kim JC, Tseng SCG. Transplantation of preserved human amniotic membrane for surface reconstruction in severely damaged rabbit corneas. Cornea. 1995; 14: Shimazaki J, Yang HY, Tsubota K. Amniotic membrane transplantation for ocular surface reconstruction in patients with chemical and thermal burn. Ophthalmology. 1997;104: Tsubota K, Satake Y, Ohyama M, et al. Surgical reconstruction of the ocular surface in advanced ocular cicatricial pemphigoid and Stevens-Johnson syndrome. Am J Ophthalmol. 1996;122: Prabhasawat P, Barton K, Burkett G, Tseng SCG. Comparison of conjunctival autografts, amniotic membrane grafts, and primary closure for pterygium excision. Ophthalmology. 1997;104: Lee SH, Tseng SCG. Amniotic membrane transplantation for persistent epithelial defects with ulceration. Am J Ophthalmol. 1997;123: Pires RT, Tseng SC, Prabhasawat P, et al. Amniotic membrane transplantation for symptomatic bullous keratopathy. Arch Ophthalmol. 1999;117: Tseng SCG, Prabhasawat P, Barton K, Gray T, Meller D. Amniotic membrane transplantation with or without limbal allografts for corneal surface reconstruction in patients with limbal stem cell deficiency. Arch Ophthalmol. 1998;116: Shore JW, Foster CS, Westfall CT, Rubin PAD. Results of buccal mucosa grafting for patients with medically controlled ocular cicatricial pemphigoid. Ophthalmology. 1992;99: Dohlman CH, Doane MG. Some factors influencing outcome after keratoprosthesis surgery. Cornea. 1994;13: Adinolfi M, Akle CA, McColl I, et al. Expression of HLA antigens, 2 -microglobulin and enzymes by human amniotic membrane. Nature. 1982;295: Akle CA, Adinolfi M, Welsh KI, Leibowitz S, McColl I. Immunogenicity of human amniotic epithelial cells after transplantation into volunteers. Lancet. 1981;2: Houlihan JM, Biro PA, Harper HM, Jenkinson HJ, Holmes CH. The human amniotic membrane is a site of MHC class 1b expression: evidence for the expression of HLA-E and HLA-G. J Immunol. 1995;154:
Table 1. Characteristics of patients. Postoperative Comorbidity acuity band keratopathy. Visual Cause of. Case Age (Yr) Sex F/U (Month)
착색양막을이용한띠각막병증의미용적치료 1459 Table 1. Characteristics of patients Case Age (Yr) Sex F/U (Month) Visual Cause of Postoperative Comorbidity acuity band keratopathy complications 1 19 M 13 NLP * PHPV Injection,
More informationAmniotic Membrane Transplantation In Ocular Surface Disorders
Orginal Article Amniotic Membrane Transplantation In Ocular Surface Disorders Khalid Iqbal Talpur, Faiz Muhammad Halepota, Muhammad Pak J Ophthalmol 2005, Vol. 22 No. 3.................................................................................................
More informationSubject Index. Atopic keratoconjunctivitis (AKC) management 16 overview 15
Subject Index Acanthamoeba keratitis, see Infective keratitis Acute allergic conjunctivitis AKC, see Atopic keratoconjunctivitis Allergy acute allergic conjunctivitis 15 atopic keratoconjunctivitis 15
More informationAmniotic membrane transplantation (AMT) without the use of sutures/fibrin glue
Original article Amniotic membrane transplantation (AMT) without the use of sutures/fibrin glue Ajai Agrawal 1, VB Pratap 2 1 Department of Ophthalmology, Kalpana Chawla Government Medical College, Karnal,
More informationTransplantation of Human Limbal Epithelium Cultivated on Amniotic Membrane for the Treatment of Severe Ocular Surface Disorders
Transplantation of Human Limbal Epithelium Cultivated on Amniotic Membrane for the Treatment of Severe Ocular Surface Disorders Jun Shimazaki, MD, Masayo Aiba, BS, Eiki Goto, MD, Naoko Kato, MD, Shigeto
More informationOcular Surface Reconstruction
OCULAR SURFACE From Tissue Transplantation to Cell Therapy Abraham Solomon, MD Abstract: The most difficult part in ocular surface reconstruction for total limbal stem cell deficiency is restoring a healthy
More informationNovel therapies for the treatment of persistent corneal epithelial defects
Novel therapies for the treatment of persistent corneal epithelial defects Disclosures I have no financial interests in any of the techniques or products discussed. Bennie H. Jeng, M.D. Associate Professor
More informationManagement of acute ulcerative and necrotising herpes simplex and zoster keratitis with amniotic membrane transplantation
1215 SCIENTIFIC REPORT Management of acute ative and necrotising herpes simplex and zoster keratitis with amniotic membrane transplantation A Heiligenhaus, H Li, E E Hernandez Galindo, J M Koch, K-P Steuhl,
More informationThe New England Journal of Medicine
The New England Journal of Medicine Copyright, 1999, by the Massachusetts Medical Society VOLUME 340 J UNE 3, 1999 NUMBER TREATMENT OF SEVERE OCULAR-SURFACE DISORDERS WITH CORNEAL EPITHELIAL STEM-CELL
More informationOur Experience in Amniotic Membrane Transplantation For Ocular SurfaceDisorders - At A Regional Ophthalmic Centre In South India
IOSR Journal of Dental and Medical Sciences (IOSR-JDMS) e-issn: 2279-0853, p-issn: 2279-0861.Volume 14, Issue 6 Ver. VI (Jun. 2015), PP 85-90 www.iosrjournals.org Our Experience in Amniotic Membrane Transplantation
More informationLiterature Summary on Uses of AmnioGraft in Ocular Surface Reconstruction. (By Dr. Scheffer CG Tseng)
Literature Summary on Uses of AmnioGraft in Ocular Surface Reconstruction I. Introduction II. Action Mechanisms III. Clinical Uses (By Dr. Scheffer CG Tseng) 1. As a Temporary Graft (Patch, Dressing, or
More informationAmniotic membrane transplantation
748 Br J Ophthalmol 1999;83:748 752 PERSPECTIVE Amniotic membrane transplantation Harminder S Dua, Augusto Azuara-Blanco In 1910 Davis was the first to report the use of fetal membranes as surgical material
More informationFailure of amniotic membrane transplantation in the treatment of acute ocular burns
Br J Ophthalmol 2001;85:1065 1069 1065 ORIGINAL ARTICLES Clinical science Failure of amniotic membrane transplantation in the treatment of acute ocular burns Annie Joseph, Harminder S Dua, Anthony J King
More informationMedicine HUMAN AMNIOTIC MEMBRANE FOR ACUTE SEVERE ALKALI BURN % VISUAL ACUITY RECOVERY
Research and Science Today No. 2(10)/2015 Medicine HUMAN AMNIOTIC MEMBRANE FOR ACUTE SEVERE ALKALI BURN - 100 % VISUAL ACUITY RECOVERY Alina GHEORGHE * Monica Daniela POP 1 Calin- Petru TATARU 2 Constantin
More informationMedical Affairs Policy
Medical Affairs Policy Service: Corneal Treatments and Specialized Contact Lenses (Corneal remodeling, Corneal transplant, Corneal collagen crosslinking, Intrastromal Rings- INTACS, Keratoconus treatments,
More informationOcular Surface Management in Corneal Transplantation, a Review
CLINICAL INVESTIGATIONS Ocular Surface Management in Corneal Transplantation, a Review Kazuo Tsubota* *Departments of Ophthalmology, Tokyo Dental College, Chiba, and Keio University School of Medicine,
More informationNEW OPPORTUNITIES OF USING THERAPEUTICAL CONTACT LENSES IN OCULAR SURGERY
NEW OPPORTUNITIES OF USING THERAPEUTICAL CONTACT LENSES IN OCULAR SURGERY Authors: Prof univ. dr. Adriana Stănilă, Dr. Elena Mihai, Dr. Adrian Teodoru, Dr. IonuŃ Costache The Clinical Department of Op
More informationrhngf for neurotrophic keratitis first line
September 2015 Horizon Scanning Research & Intelligence Centre rhngf for neurotrophic keratitis first line LAY SUMMARY This briefing is based on information available at the time of research and a limited
More informationSclerokeratoplasty David S. Chu, M.D. Cases
Sclerokeratoplasty David S. Chu, M.D. Cases Case 1 40 year-old female from Peru presented to our Service with inflamed OS for 2 months duration. Her symptoms began as red painful OS, which progressively
More informationTHERAPEUTIC CONTACT LENSES
THERAPEUTIC CONTACT LENSES Prof. Univ. Dr. Adriana Stanila Victor Papilian Faculty of Medicine Emergency Academic Hospital Sibiu Ocular Surface Research Center ROMANIA INTRODUCTION therapeuein greac =
More informationReconstruction of conjunctiva with amniotic membrane after excision of large conjunctival melanoma: A long-term study
E u ropean Journal of Ophthalmology / Vol. 15 no. 4, 2005 / pp. 4 4 6-4 5 0 Reconstruction of conjunctiva with amniotic membrane after excision of large conjunctival melanoma: A long-term study G. DALLA
More informationLong-term outcome of allogeneic cultivated limbal epithelial transplantation for symblepharon caused by severe ocular burns
Cheng et al. BMC Ophthalmology (2017) 17:8 DOI 10.1186/s12886-017-0403-9 TECHNICAL ADVANCE Open Access Long-term outcome of allogeneic cultivated limbal epithelial transplantation for symblepharon caused
More informationAmniotic membrane transplantation for partial limbal stem cell deficiency
Br J Ophthalmol 2001;85:567 575 567 ORIGINAL ARTICLES Clinical science Amniotic membrane transplantation for partial limbal stem cell deficiency David F Anderson, Pierre Ellies, Renato T F Pires, ScheVer
More informationThe Results of Amniotic Membrane Transplantation for Symptomatic Bullous Keratopathy
The Results of Amniotic Membrane Transplantation for Symptomatic Bullous Keratopathy Orathai Chansanti MD*, Orasa Horatanaruang MD* * Department of Ophthalmology, Faculty of Medicine, Songklanagarind Hospital,
More informationAmniotic membrane transplantation for partial limbal stem cell deficiency
Br J Ophthalmol 2001;85:567 575 567 ORIGINAL ARTICLES Clinical science Ocular Surface and Tear Center, Department of Ophthalmology, Bascom Palmer Eye Institute, Miami, Florida, USA D F Anderson P Ellies
More informationOriginal Research Article
STUDY OF EPITHELIAL PHENOTYPE AFTER PTERYGIUM EXCISION BY USING CONJUNCTIVAL IMPRESSION CYTOLOGY. Dr. Sachin O. Agrawal*, Dr. Sudhir Pendke, Dr. Ravi Chauhan Department of Ophthalmology, Indira Gandhi
More informationLong-term results of autologous cultivated oral mucosal epithelial transplantation in the scar phase of severe ocular surface disorders
1 Department of Ophthalmology, Kyoto Prefectural University of Medicine, Graduate School of Medicine, Kyoto, Japan 2 Research Center for Inflammation and Regenerative Medicine, Doshisha University, Kyoto,
More informationThe recurrence of pterygium after different modalities of surgical treatment
Saudi Journal of Ophthalmology (2011) 25, 411 415 King Saud University Saudi Journal of Ophthalmology www.saudiophthaljournal.com www.ksu.edu.sa www.sciencedirect.com ORIGINAL ARTICLE The recurrence of
More informationBlood Derived Therapies in Refractory Ocular Surface Disease
Blood Derived Therapies in Refractory Ocular Surface Disease John E. Conto, OD, FAAO, ABCMO Assistant Professor of Ophthalmology and Visual Science Please silence all mobile devices and remove items from
More informationLIMBAL TRANSPLANTATION IN THE MANAGEMENT OF CHRONIC CONTACT-LENS-ASSOCIATED EPITHELIOPATHY
LIMBAL TRANSPLANTATION IN THE MANAGEMENT OF CHRONIC CONTACT-LENS-ASSOCIATED EPITHELIOPATHY CHRISTOPHER JENKINS, STEPHEN TUFT, CHRISTOPHER LIU and ROGER BUCKLEY London SUMMARY We describe the clinical management
More informationAmniotic membrane graft for primary pterygium: comparison with conjunctival autograft and topical mitomycin C treatment
Br J Ophthalmol 2000;84:973 978 973 Department of Ophthalmology, Chang Gung Memorial Hospital, Taoyuan, Taiwan D H-K Ma S-B Liau R J-F Tsai Department of Public Health, College of Medicine, Chang Gung
More informationJMSCR Volume 03 Issue 01 Page January 2015
www.jmscr.igmpublication.org Impact Factor 3.79 ISSN (e)-2347-176x Pterygium Excision and Conjunctival Autograft A Study Authors Dr. M. Premanandam 1, Dr. A. Geetha 2, Dr. Himabindu 3 1 MS, Associate Professor,
More informationFitting Keratoconus and Other Complicated Corneas
Fitting Keratoconus and Other Complicated Corneas Christine W Sindt OD FAAO Professor, Clinical Ophthalmology Director, Contact Lens Service University of Iowa Disclosure Consultant: ALCON Vision Care
More informationMustard Gas Induced Ocular Surface Disorders
Challenging Case Mustard Gas Induced Ocular Surface Disorders Section Editor: Alireza Baradaran-Rafii, MD Ophthalmic Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran Sulfur
More informationT he normal ocular surface is covered with highly
1280 EXTENDED REPORT Transplantation of cultivated autologous oral mucosal epithelial cells in patients with severe ocular surface disorders T Nakamura, T Inatomi, C Sotozono, T Amemiya, N Kanamura, S
More informationAmniotic Membrane Transplantation
Amniotic Membrane Transplantation Alireza Baradaran-Rafii, MD 1 ; Hamid-Reza Aghayan, MD 2 ; Babak Arjmand, MD 2 ; Mohammad-Ali Javadi, MD 1 1Shaheed Beheshti Medical University, Tehran, Iran; 2 Iranian
More informationAmniotic Membrane Transplantation for Pseudomonal Keratitis with Impending Perforation
Original Article 144 Amniotic Membrane Transplantation for Pseudomonal Keratitis with Impending Perforation Jesse Hung-Chi Chen, MD; David Hui-Kang Ma, MD, PhD; Ray Jui-Fang Tsai, MD Background: To determine
More informationHuman lamellar tendon graft in corneal surgery
Human lamellar tendon graft in corneal surgery Armando Signorelli, Jr, MD, Carlos Roberto Signorelli, MD, Ernest Rifgatovich Muldashev, MD Refractive and Corneal surgery - 1993 - V.9(2) - P. 135-139 ABSTRACT
More informationVarious therapies for ocular surface diseases
Romanian Journal of Ophthalmology, Volume 62, Issue 1, January-March 2018. pp:83-87 CASE REPORT Various therapies for ocular surface diseases Gheorghe Alina*, Rosoga Ancuţa Teodora**, Mrini Fildys*, Vărgău
More informationJ Med Bacteriol. Vol.1, No. 1, 2 (2012) : pp jmb.tums.ac.ir
J Med Bacteriol. Vol.1, No. 1, 2 (2012) : pp. 31-37 jmb.tums.ac.ir ISMB TUMS Effect of Amniotic Membrane Combined with Ciprofloxacin in Curing the Primary Stages of Pseudomonal Keratitis Mohammad Mehdi
More informationD JO. Conjunctivolimbal Autograft versus Cadaveric Keratolimbal Allograft in Ocular Surface Disorder: A Comparison
20 Conjunctivolimbal Autograft versus Cadaveric Keratolimbal Allograft in Ocular Surface Disorder: A Comparison Jaya Kaushik 1-2, Jitendra Kumar Singh Parihar 1, Vaibhav Kumar Jain 3, Vijay Mathur 1 1
More informationCourse # Cutting Edge Cornea
Course # 061 Cutting Edge Cornea 44 year old female with sudden onset right eye pain. Has happened 3 times previouslyevery time first thing in the morning Cutting Edge Cornea Terri Kim, M.D. Chairman,
More informationCornea & External Disease research at Moorfields
Recruiting Research Studies Cornea & External Disease research at Moorfields Moorfields Eye Hospital wants to improve access to clinical research studies for all patients within the NHS and provide the
More informationSeong-Kyu Im, Kwang-Hoon Lee, Kyung-Chul Yoon. Department of Ophthalmology, Chonnam National University Medical School, Gwangju, Korea
pissn: 1011-8942 eissn: 2092-9382 Korean J Ophthalmol 2010;24(2):73-77 DOI: 10.3341/kjo.2010.24.2.73 Combined Ethylenediaminetetraacetic Acid Chelation, Phototherapeutic Keratectomy and Amniotic Membrane
More informationImplantation of a corneal graft keratoprosthesis for severe corneal opacity in wet blinking eyes
NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE Interventional procedure consultation document Implantation of a corneal graft keratoprosthesis for severe corneal opacity in wet blinking eyes The cornea
More informationCLINICALLY, LIMBAL STEM
CLINICAL SCIENCES Phenotypic Study After Cultivated Limbal Epithelial Transplantation for Limbal Stem Cell Deficiency Motoko Kawashima, MD; Tetsuya Kawakita, MD; Yoshiyuki Satake, MD; Kazunari Higa, PhD;
More informationGas Permeable Scleral Contact Lens. Description
Subject: Gas Permeable Scleral Contact Lens Page: 1 of 6 Last Review Status/Date: December 2013 Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 3 Gas Permeable
More informationComparison of prognostic value of Roper Hall and Dua classification systems in acute ocular burns
1 Cornea and Refractive Surgery Services, Dr Rajendra Prasad Centre for Ophthalmic Sciences, All India Institute of Medical Sciences, New Delhi, India 2 Department of Biostatistics, All India Institute
More informationNIH Public Access Author Manuscript Expert Rev Ophthalmol. Author manuscript; available in PMC 2011 August 1.
NIH Public Access Author Manuscript Published in final edited form as: Expert Rev Ophthalmol. 2010 October ; 5(5): 645 661. doi:10.1586/eop.10.63. Update on amniotic membrane transplantation Jingbo Liu
More informationOCULAR HERPES simplex virus
CLINICAL SCIENCES Oral Acyclovir After Penetrating Keratoplasty for Herpes Simplex Keratitis Fabiana P. Tambasco, MD; Elisabeth J. Cohen, MD; Lien H. Nguyen, MD; Christopher J. Rapuano, MD; Peter R. Laibson,
More informationCORNEAL COMPLICATIONS OF INTRAOPERATIVE MITOMYCIN C IN GLAUCOMA SURGERY COPPENS G., MAUDGAL P.
CORNEAL COMPLICATIONS OF INTRAOPERATIVE MITOMYCIN C IN GLAUCOMA SURGERY COPPENS G., MAUDGAL P. ABSTRACT Purpose: To report corneal toxicity of Mitomycin C application during filtering glaucoma surgery
More informationFEP Medical Policy Manual
FEP Medical Policy Manual Effective Date: April 15, 2018 Related Policies: 2.01.16 Recombinant and Autologous Platelet-Derived Growth Factors for Healing and Other Non Orthopedic Conditions 7.01.113 Bioengineered
More informationFEP Medical Policy Manual
FEP Medical Policy Manual Effective Date: July15, 2017 Related Policies: 2.01.16 Recombinant and Autologous Platelet-Derived Growth Factors for Healing and Other Non Orthopedic Conditions 7.01.113 Bioengineered
More informationLearning Objectives. Disclosures 2/2/ BMT Pharmacists Conference Bandage Contact Lens Therapy for Severe Ocular GVHD
2015 BMT Pharmacists Conference Bandage Contact Lens Therapy for Severe Ocular GVHD Tueng T. Shen, M.D., Ph.D. Professor of Ophthalmology Adjunct, Bioengineering and Global Health Feb. 13 th, 2015 Learning
More informationCorporate Medical Policy
Corporate Medical Policy File Name: Origination: Last CAP Review: Next CAP Review: Last Review: endothelial_keratoplasty 9/2009 6/2018 6/2019 6/2018 Description of Procedure or Service Endothelial keratoplasty
More informationBreaking the Cycle. Yijie (Brittany) Lin, MD, MBA, Reena Garg, MD New York Eye and Ear Infirmary of Mount Sinai
Lin, Garg Ophthalmology Times 1 Breaking the Cycle Yijie (Brittany) Lin, MD, MBA, Reena Garg, MD New York Eye and Ear Infirmary of Mount Sinai Abstract A 32 year-old female with a history of LASIK surgery
More informationCorporate Medical Policy
Corporate Medical Policy Keratoprosthesis File Name: Origination: Last CAP Review: Next CAP Review: Last Review: keratoprosthesis 11/1989 6/2017 6/2018 6/2017 Description of Procedure or Service A keratoprosthesis,
More informationCORNEAL CONDITIONS CORNEAL TRANSPLANTATION
GENERAL INFORMATION CORNEAL CONDITIONS CORNEAL TRANSPLANTATION WHAT ARE CORNEAL CONDITIONS? The cornea is the clear outer layer of the eye. Shaped like a dome, it helps to protect the eye from foreign
More informationLimbal-Conjunctival Autograft Transplantation for the Management of Primary Pterygium
Limbal-Conjunctival Autograft Transplantation for the Management of Primary Pterygium Mahmoud Jabbarvand, MD, 1 Mohammad-Reza Khalili, MD 2 Mohammad-Taher Rajabi, MD 3 Abstract Purpose: To investigate
More informationStrategies for Anterior Segment Disease Management Mile Brujic, OD, FAAO 1409 Kensington Blvd Bowling Green, OH
Strategies for Anterior Segment Disease Management Mile Brujic, OD, FAAO 1409 Kensington Blvd Bowling Green, OH 43402 brujic@prodigy.net 419-261-9161 Summary As optometry s scope of practice continues
More informationParacentral Corneal Melting in Four Patients With Chronic Graft-Versus-Host Disease
Paracentral Corneal Melting in Four Patients With Chronic Graft-Versus-Host Disease Neil Chungfat, MD, MEng 1,2 ; Jocelyn Rowe, MD 1,3 ; Neal P. Barney, MD 1 ; Sarah Nehls, MD 1 The authors have no financial
More informationCorneal specimens that influence clinical decisions
Corneal specimens that influence clinical decisions Refractive surgery Corneal dystrophies Microbial infections J. Douglas Cameron, MD Chief, Ophthalmic Pathology Division Neuropathology Department Armed
More informationTISSUE-SPECIFIC PROGENITOR AND STEM CELLS
SM TISSUE-SPECIFIC PROGENITOR AND STEM CELLS Concise Review: Limbal Stem Cell Deficiency, Dysfunction, and Distress SAJJAD AHMAD Key Words. Cornea Corneal epithelium Limbal stem cell Limbal stem cell deficiency
More informationA new classification of ocular surface burns
Br J Ophthalmol 2001;85:1379 1383 1379 PERSPECTIVE A new classification of ocular surface burns Harminder S Dua, Anthony J King, Annie Joseph Ocular burns constitute true ocular emergencies and both thermal
More informationFUCH S DYSTROPHY & CATARACT SURGERY TREATMENT ALGORITHM
FUCH S DYSTROPHY & CATARACT SURGERY TREATMENT ALGORITHM ΙΟΑΝΝΙS Α. MALLIAS, MD, PHD Director of the Dept. of Ophthalmology, Mediterraneo Hospital, Glyfada, Athens, Greece Clinical Fellow in Cornea and
More informationPROSE Treatment Information for Patients and Doctors
PROSE Treatment Information for Patients and Doctors prior to getting my PROSE devices, life was hard. Everything that I loved to do was slipping away...that all changed the day I got PROSE. PROSE patient
More informationMATERIALS AND METHODS
Clinical Trials Evaluation of Cord Therapy in Acute Ocular Chemical Burns Namrata Sharma, 1 Manik Goel, 1 Thirumurthy Velpandian, 1 Jeewan S. Titiyal, 1 Radhika Tandon, 1 and Rasik B. Vajpayee 1,2,3 From
More informationSurgeon Preference Form
Surgeon Preference Form Please complete this form and fax it to 608.338.0044. If you have any questions, please contact our Tissue Distribution Coordinator at 877.233.2354 option 2. LEBW looks forward
More information8/11/2017. Rob Allen, O.D. Rob Allen, Ph.D. Rob Allen, O.D. None. Rob Allen, Ph.D. Represents BioD/BioDOPTIX Amniotic Membrane
Rob Allen, O.D. Rob Allen, Ph.D. VisionAmerica August 25, 2017 Rob Allen, O.D. None Rob Allen, Ph.D. Represents BioD/BioDOPTIX Amniotic Membrane Rob Allen, O.D. Rob Allen, Ph.D. 1 Rob Allen, O.D. Rob Allen,
More informationPhotochemical corneal collagen cross-linkage using riboflavin and ultraviolet A for keratoconus and keratectasia
Photochemical corneal collagen cross-linkage using riboflavin and ultraviolet A for keratoconus and keratectasia Issued: September 2013 guidance.nice.org.uk/ipg466 NICE has accredited the process used
More informationINDOLENT ULCER IN BOXER. Dr n. wet. Przemysław K. Bryla Przychodnia weterynaryjna w Warszawie INTRODUCTION
Dr n. wet. Przemysław K. Bryla Przychodnia weterynaryjna w Warszawie brylapik@wp.pl SUMMARY A case of indolent ulcer in a Boxer is described. An indolent ulcer is a ulcer which fails to heal in the expected
More informationInterventional procedures guidance Published: 25 September 2013 nice.org.uk/guidance/ipg466
Photochemical corneal collagen cross-linkage using riboflavin and ultraviolet A for keratoconus and keratectasia Interventional procedures guidance Published: 25 September 2013 nice.org.uk/guidance/ipg466
More informationSelected Diseases of the Cornea Dick Dubielzig July 20 th, 2009
Selected Diseases of the Cornea Dick Dubielzig July 20 th, 2009 Canine Collagenolytic Keratitis Canine Collagenolytic Keratitis 270 cases (1.5%) Usually associated with suppurative keratitis Collagenolytic
More informationPostoperative follow up and treatment after refractive surgery
Postoperative follow up and treatment after refractive surgery George Kontadakis, MD, MSc, PhD Institute of Vision and Optics and Department of Ophthalmology University of Crete Target of postoperative
More informationCorneal Epithelial Wound Healing in the Absence of Limbal Epithelium
Investigative Ophthalmology & Visual Science, Vol. 32, No. 1, January 1991 Copyright Association for Research in Vision and Ophthalmology Corneal Epithelial Wound Healing in the Absence of Limbal Epithelium
More informationThe Effect of In Vivo Grown Corneal Epithelium Transplantation on Persistent Epithelial Defects with Limbal Stem Cell Deficiency
J Korean Med Sci 2008; 23: 502-8 ISSN 1011-8934 DOI: 10.3346/jkms.2008.23.3.502 Copyright The Korean cademy of Medical Sciences The Effect of In Vivo Grown Corneal Epithelium Transplantation on Persistent
More informationCHEMICAL INJURY IS ONE OF
CLINICAL SCIENCES Temporary Sutureless Amniotic Membrane Patch for Acute Alkaline Burns Ahmad Kheirkhah, MD; Daniel A. Johnson, MD; Deval R. Paranjpe, MD; V.K. Raju, MD, FRCS; Victoria Casas, MD; Scheffer
More informationMELTING CORNEAL ULCERS IN HORSES: DIAGNOSIS AND TREATMENT METHODS
Vet Times The website for the veterinary profession https://www.vettimes.co.uk MELTING CORNEAL ULCERS IN HORSES: DIAGNOSIS AND TREATMENT METHODS Author : FERNANDO MALALANA Categories : Vets Date : October
More informationOutcome of Penetrating Keratoplasty from a Corneal Unit in Pakistan
Original Article Outcome of Penetrating Keratoplasty from a Corneal Unit in Pakistan Muhammad Nasir Bhatti, Yawar Zaman, P.S. Mahar, Azizur Rahman, Muhammad Fazal Kamal, Mazhar-ul-Hassan, Partab Rai Pak
More informationWhat are some common conditions that affect the cornea?
What are some common conditions that affect the cornea? Injuries After minor injuries or scratches, the cornea usually heals on its own. Deeper injuries can cause corneal scarring, resulting in a haze
More informationPATIENT INFORMATION ON CORNEAL GRAFT
PATIENT INFORMATION ON CORNEAL GRAFT (TRANSPLANT) SURGERY M ANANDAN What is the cornea? The clear window of the eye approximately 0.5mm thick and 12mm across. It lies in front of the fluid filled anterior
More informationCLINICAL INPUT RESPONSES
CLINICAL INPUT RESPONSES Additional Comments With regard to the 9 indications listed above, there was lower range confidence that there is adequate evidence demonstrating that sutureless fixation human
More informationStevens Johnson syndrome (SJS) is a relatively rare, acute,
CLINICAL SCIENCE Indications and Outcomes of Amniotic Membrane Transplantation in the Management of Acute Stevens Johnson Syndrome and Toxic Epidermal Necrolysis: A Case Control Study Maylon Hsu, MD, Anupam
More informationProtocol. Endothelial Keratoplasty
Protocol Endothelial Keratoplasty (90322) Medical Benefit Effective Date: 04/01/14 Next Review Date: 11/18 Preauthorization No Review Dates: 01/14, 11/14, 11/15, 11/16, 11/17 Preauthorization is not required.
More informationClinical Policy Title: Therapeutic contact lenses
Clinical Policy Title: Therapeutic contact lenses Clinical Policy Number: 10.02.02 Effective Date: June 1, 2014 Initial Review Date: December 18, 2013 Most Recent Review Date: January 11, 2018 Next Review
More informationCHAPTER 2 CORNEAL TRANSPLANTATION. Editors: Dr. Shamala Retnasabapathy Dr. Choong Yean Yaw Dr. Michael Law Sie Haur
CHAPTER 2 Editors: Dr. Shamala Retnasabapathy Dr. Choong Yean Yaw Dr. Michael Law Sie Haur Expert Panel: Dr. Shamala Retnasabapathy (Chair) Dr. Choong Yean Yaw (Co-chair) Dr. Jonathan Choon Siew Cheong
More informationEye Care for Animals Micki Armour VMD DACVO THE CORNEA
Eye Care for Animals Micki Armour VMD DACVO THE CORNEA ANATOMY 0.5-0.6mm thick 4 primary layers Epithelium (5-7 cell layers) Stroma (90% total thickness) Descemet s membrane Endothelium (1 layer) ANATOMY-
More informationClinical Study Improvement of Amniotic Membrane Method for the Treatment of Corneal Perforation
BioMed Research International Volume 2016, Article ID 1693815, 8 pages http://dx.doi.org/10.1155/2016/1693815 Clinical Study Improvement of Amniotic Membrane Method for the Treatment of Corneal Perforation
More informationEfficacy of Photorefractive Keratectomy for Military Pilot Recruitment in an Asian Air Force
Efficacy of Photorefractive Keratectomy for Military Pilot Recruitment in an Asian Air Force Brian See, Gerard Nah, Wee Hoe Gan, Robin Low AsMA Annual Scientific Meeting 2013 Chicago, IL, USA Disclosure
More informationPlease silence all mobile devices and remove items from chairs so others can sit. Unauthorized recording of this session is prohibited.
Reviving the Limbus: The importance of the limbal stem cell niche & techniques to rehabilitate the ocular surface Scott G. Hauswirth, OD, FAAO Director, Ocular Surface Center, Sue Anschutz-Rogers Eye Center
More informationHistory- RCES. Recurrent Corneal Erosion Syndrome -update. Epidemiology. Etiology/Pathogenesis 12/3/2011
History- RCES Recurrent Corneal Erosion Syndrome -update Bruce D. Gaynor, MD FI Proctor Foundation UCSF Recognized disease entity >100 years 1872- Hansen intermittent neuralgic vesicular keratitis antecedent
More informationSummary. Introduction
Murgova S., Balabanov Ch. Corneal melting Case report CORNEAL MELTING Snejana Murgova, Chavdar Balabanov Eye Clinic, University Hospital D-r Georgi Stranski Pleven Summary Corneal melting is a form of
More informationDifferential Diagnosis of Conjunctivitis and Keratoconjunctivitis
Differential Diagnosis of Conjunctivitis and Keratoconjunctivitis Dr. Victor Malinovsky 2006 Mechanical-Physical Trauma Corneal Abrasions Abrasions (interpalpebral/variable): a focal loss of epithelium
More informationDystrophies. Molecular Causes. Anterior Membrane Dystrophies (epithelium, basement membrane and Bowman s layer)
Dystrophies Characteristics of corneal dystrophies About half the members of appropriate age to have the dystrophy( usually autosomal dominant): inherited Usually seen in the first or second decade of
More informationCodes for Medically Necessary Contact Lenses
Codes for Medically Necessary Contact Lenses CPT Codes for Medically Necessary Prescribing Preamble for the 9231X Codes The prescription of contact lenses includes specification of optical and physical
More informationOcular Surface Stem Cells and Disease: Current Concepts and Clinical Applications
576 Review Article Ocular Surface Stem Cells and Disease: Current Concepts and Clinical Applications LPK Ang, 1,2,3 FRCS (Edin), MRCOphth, M Med (Ophth), DTH Tan, 1,2,3 FRCS (Glas), FRCOphth, FAMS Abstract
More informationComparison of the surgical outcome between Wet Amniotic Membrane Graft (Wet AMG), Conjunctival Autograft (CAG) and Topical Mitomycin C (MMC)
Original article Comparison of the surgical outcome between Wet Amniotic Membrane Graft (Wet AMG), Conjunctival Autograft (CAG) and Topical Mitomycin C (MMC) 1 Dr Pavitra Patel*, 2 Dr Sachin Daigavane,
More informationA Novel Application of Amniotic Membrane in Patients with Bullous Keratopathy
J Korean Med Sci 2006; 21: 324-8 ISSN 1011-8934 Copyright The Korean Academy of Medical Sciences A Novel Application of Amniotic Membrane in Patients with Bullous Keratopathy To evaluate the efficacy of
More information(12) United States Patent (10) Patent No.: US 6,326,019 B1
USOO6326019B1 (12) United States Patent (10) Patent No.: Tseng () Date of Patent: Dec. 4, 2001 (54) GRAFTS MADE FROM AMNIOTIC Prabhasawat, et al., Comparison of Conjunctival MEMBRANE; METHODS OF SEPARATING,
More informationEffects of lyophilization on human amniotic membrane
Effects of lyophilization on human amniotic membrane M. Teresa Rodríguez-Ares, 1 María J.Lo pez-valladares, 1 Rosario Tourin o, 1 Begon a Vieites, 2 Francisco Gude, 3 María T. Silva 4 and Jose Couceiro
More information